Inositol for PCOS: Dosage, Benefits, and Results

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-age women, affecting approximately 10% of the population. At its core, PCOS in most women involves insulin resistance, excess insulin driving androgen production in the ovaries, disrupting ovulation, and creating a cascade of hormonal and metabolic consequences.

Inositol, specifically the myo-inositol form, has emerged as one of the best-evidenced nutritional interventions for the insulin-resistance pathway in PCOS. This guide covers the complete evidence base, dosing protocols, and what realistic results look like.

Pin it

What Is Inositol?

Inositol is a naturally occurring carbohydrate (sometimes called a B-vitamin, though technically it's not a vitamin) found in many foods, particularly fruits, grains, and nuts. Nine naturally occurring forms of inositol exist; two are relevant to PCOS supplementation:

Myo-inositol (MI): The most abundant form. Functions as a secondary messenger in insulin signalling, it's required for the downstream effects of insulin to work properly. Deficiency or altered metabolism of myo-inositol impairs insulin signalling.

D-chiro-inositol (DCI): Produced from myo-inositol through an insulin-stimulated epimerase enzyme. Involved in different downstream insulin signalling pathways. Important in the ovary for androgen synthesis regulation.

In women with insulin-resistant PCOS, this conversion pathway is impaired, leading to elevated myo-inositol and deficient D-chiro-inositol in some tissues (particularly the ovary), while paradoxically having excess D-chiro-inositol in others.

The PCOS-Inositol Connection

The Insulin Problem in PCOS

In the most common (insulin-resistant) PCOS phenotype:

1. Insulin resistance in peripheral tissues → pancreas secretes more insulin to compensate
2. High insulin → ovarian theca cells stimulated to produce excess androgens (testosterone, DHEA)
3. High androgens → disrupted follicle development → anovulation (no ovulation)
4. No ovulation → irregular or absent periods
5. No ovulation → no progesterone → unopposed oestrogen → further hormonal imbalance

Breaking this cycle requires improving insulin sensitivity, and inositol directly targets the insulin signalling pathway.

How Myo-Inositol Helps

Myo-inositol is a component of the phosphatidylinositol signalling pathway, one of the primary intracellular pathways through which insulin exerts its effects. Supplementing myo-inositol:

• Improves insulin receptor signalling sensitivity
• Reduces fasting insulin levels
• Improves HOMA-IR (insulin resistance index)
• Reduces LH (luteinising hormone), normalising the elevated LH seen in PCOS
• Reduces testosterone levels
• Supports FSH signalling in follicle development

The Clinical Evidence

Hormonal Effects

Testosterone reduction: Multiple RCTs show myo-inositol significantly reduces total and free testosterone in PCOS women over 3–6 months.

LH:FSH ratio: Elevated LH relative to FSH is a hallmark of PCOS, myo-inositol reduces LH toward normal range.

Androgen symptoms: Improvements in acne and hirsutism are reported in several trials, consistent with reduced androgen levels.

Menstrual Cycle Restoration

Ovulation and cycle regularity: Several RCTs show myo-inositol restores regular cycles in anovulatory PCOS women. A 2007 Italian study (Gerli et al.) found 25 of 25 women taking myo-inositol restored ovulation within 6 months, compared to limited response in the placebo group.

Pregnancy rates: Myo-inositol improves spontaneous pregnancy rates in PCOS women trying to conceive, a clinically significant finding.

Metabolic Effects

Insulin sensitivity: Consistent improvement in HOMA-IR, fasting insulin, and glucose tolerance across multiple trials.

Weight: Modest weight loss of 1–3kg over 3–6 months in most trials, not dramatic, but meaningful given the difficulty of weight loss with PCOS.

Lipid profile: Some studies show modest improvements in triglycerides and cholesterol.

Comparison with Metformin

Several head-to-head trials compare myo-inositol with metformin in PCOS:

• Both improve insulin sensitivity and restore ovulation
• Myo-inositol shows fewer GI side effects (metformin causes significant nausea and diarrhoea in many women)
• Some trials show similar efficacy; others favour one or the other depending on the outcome measured
• Combination therapy shows additive benefit in some trials

Pin it

Dosage Protocol

Standard PCOS Protocol

Myo-inositol: 4,000mg/day (4g) D-chiro-inositol: 100mg/day (to achieve the 40:1 ratio)

Take split into two doses, 2,000mg MI + 50mg DCI twice daily, with meals.

Most commercial products marketed for PCOS use this 40:1 ratio in a single product.

Why the 40:1 Ratio Matters

The physiological ratio of myo-inositol to D-chiro-inositol in follicular fluid is 40:1. Disrupting this ratio, particularly by taking high doses of D-chiro-inositol alone, can paradoxically worsen ovarian function in some women (the "ovarian DCI paradox"). Products containing D-chiro-inositol alone or at ratios lower than 40:1 should be approached cautiously.

Alternatives to the 4,000mg/40:1 Protocol

Some studies use myo-inositol alone at lower doses with results. If the 40:1 ratio product is unavailable, myo-inositol at 2,000–4,000mg/day alone is a reasonable starting point based on the original Italian research.

Managing Expectations: What Inositol Can and Cannot Do

Inositol can:

• Improve insulin sensitivity
• Reduce testosterone and LH in insulin-resistant PCOS
• Restore or improve cycle regularity in many women
• Modestly support weight loss
• Reduce androgen symptoms over 3–6 months

Inositol cannot:

• Replace dietary change and exercise (which are more impactful overall)
• Guarantee pregnancy (though it improves odds)
• Fully treat structural or non-insulin-resistant PCOS variants
• Work quickly, significant changes take 3–6 months

PCOS is not one condition: The term covers multiple phenotypes. Inositol's strongest evidence is in insulin-resistant PCOS. Non-obese PCOS without significant insulin resistance may see smaller benefits. Lean PCOS often has a different primary driver (often LH excess) where inositol may still help but response varies more.

Supporting Inositol with Diet and Lifestyle

For maximum impact, combine inositol supplementation with:

Diet:

• High protein (1.8–2g/kg), supports satiety and insulin sensitivity
• Low-glycaemic carbohydrates (legumes, oats, sweet potato)
• Reduced ultra-processed foods
• Adequate fibre (30g+/day)

Exercise:

• Resistance training 3–4x/week (most impactful for insulin sensitivity)
• Moderate cardio 2–3x/week

Additional supplements to consider:

• Berberine: complementary insulin sensitiser (see our berberine guide)
• Magnesium: insulin signalling support
• Vitamin D: deficiency worsens PCOS severity

For the complete 8-week PCOS action plan, see our PCOS Weight Loss Guide.

The Bottom Line

Myo-inositol at the 40:1 ratio (4,000mg MI + 100mg DCI) is one of the best-evidenced nutritional interventions specifically for insulin-resistant PCOS. It improves insulin sensitivity, reduces testosterone, and restores ovulation in many women, with a safety profile considerably better than metformin.

It is not a quick fix. Give it 3–6 months. Combine with dietary changes and resistance training for the best results. Discuss with your GP or gynaecologist if you're planning pregnancy.